Evotec Wins $5M First Milestone Payment from Celgene in Neuro Partnership

Evotec said today it has won a $5 million first milestone payment from Celgene in the companies’ 10-month-old, up-to-$295 million-plus partnership to create treatments for neurodegenerative diseases that include amyotrophic lateral sclerosis (ALS), Alzheimer's disease, and Parkinson's disease.The milestone payment follows the successful completion of a screening campaign using Evotec’s induced pluripotent stem cell (iPSC)-based screening platform, the company said.Celgene agreed to u